Dupuytren Disease. Júlio André, Fernando Cruz, Mª José Maio

Embed Size (px)

Citation preview

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    1/23

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    2/23

    Dupuytren Disease

    Pedro Simas

    Leonor Fernandes

    Teresa Marques

    Jlio Andr Almeida

    Hospital Garcia de Orta - Almada

    Director - Dr. Craveiro Lopes

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    3/23

    Introduction

    1st described Guillaume Dupuytren (1831)

    Palmar Fibromatosis

    Incidence male related

    Prevalence northern Europe

    Risk factors diabetes, alcohol, tobacco

    PIP contracture 4th and 5th fingers

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    4/23

    PIP Contracture

    Amputation ofmedial and distal phalanx

    Ressection ofmedial phalange Arthrodesis

    Open

    Fixation with Kirschner wire

    Joint replacement???

    Persistent deformity after distal selective fascectomy

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    5/23

    PIP Contracture

    Phalanx or finger mostly 5th finger

    Severe functional deficit or vascular injury

    Recurrent disease

    Amputation of the medial and distal phalange

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    6/23

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    7/23

    PIP Contracture

    Open or fixation with K-wire

    Good functional outcome

    DIP extension Pseudoboutonnire

    Arthrodesis

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    8/23

    Material and Methods

    2000-2006

    119 patients operated

    102 patients evaluated 120 hands 196 rays

    7 PIP arthrodesis

    16 complications

    4 reoperated

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    9/23

    Objectives

    Evaluate the influence of comorbidities

    diabetes

    Evaluate the influence of tobacco and alcohol in

    the prevalence and evolution of the disease

    Evaluate the quality of treatment

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    10/23

    Results

    Gender

    M:F = 6:1

    Age of beginning of the disease

    Average interval between beginning the disease and surgery 10,78 years

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    11/23

    Results

    Operated rays

    Bilateral cases 17 patients

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    12/23

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    13/23

    Results

    Tobacco Alcohol

    Positive family history 18%

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    14/23

    Results Comorbidities Hand pathology

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    15/23

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    16/23

    Results

    Complications

    Sudecks athrophy 3

    Dysesthesia 9

    Infection 3

    Hypertrophic scars 1

    Skin cicatrization problems 15

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    17/23

    Results

    Patients satisfaction

    Exc

    elle

    nt

    Goo

    dP

    oor

    Fair

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    18/23

    Analysis of Results

    Diabetes

    Complications

    - Diabetes: 46% and No-diabetes: 18%

    Recurrences

    - Diabetes: 30% and No-diabetes: 17%

    Tubiana Classification Post-operative

    Diabetes 1,14 (0-3)No-diabetes 0,67 (0-3)

    p

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    19/23

    Analysis of Results

    AlcoholPost-operative

    Alcohol 0,91 (0-3)No-alcohol 0,59 (0-3)

    Tubiana Classification

    Complications

    - Alcohol: 24% and No-alcohol: 33%

    Recurrences

    - Alcohol: 19% and No-alcohol: 21%

    p>0,01

    p>0,01

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    20/23

    Tubiana Classification Post-operative

    Smoking 0,83 (0-3)Non-smoking 0,88 (0-3)

    Analysis of Results

    Tobacco

    Complications

    - Smoking: 28% and Non-smoking: 26%

    Recurrences

    - Smoking: 18% and Non-smoking: 22%

    p>0,01

    p>0,01

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    21/23

    PIP arthrodesis

    Persistent deformity uncorrected by distal fascectomy

    Arthrodesis fixation with Kirschner wires

    6 patients/ 7 raysGender Diabetes Tobacco Ray Recurrency Satisfaction

    M Yes Yes R5 Yes Good

    F Yes No R5 Yes Good

    M No No R4,R5 No Fair

    M No Yes R5 No Fair

    M No Yes R5 No Bad

    M No No R5 No Deceased

    Analysis of Results

    PIP

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    22/23

    Conclusions

    Excellent and good results: 74%

    Diabetes related to disease recurrence and complications

    Tobacco and Alcohol not related? ( other studies)

    PIP arthrodesis small n of patients

    PIP arthrodesis better results in recurrent disease?

  • 8/6/2019 Dupuytren Disease. Jlio Andr, Fernando Cruz, M Jos Maio

    23/23

    OBRIGADO!